127 related articles for article (PubMed ID: 34154847)
1. Factors affecting prognosis of the patients with severe hyponatremia.
Turkmen E; Karatas A; Altindal M
Nefrologia (Engl Ed); 2021 Jun; ():. PubMed ID: 34154847
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting prognosis of the patients with severe hyponatremia.
Turkmen E; Karatas A; Altindal M
Nefrologia (Engl Ed); 2022; 42(2):196-202. PubMed ID: 36153916
[TBL] [Abstract][Full Text] [Related]
3. Sodium Correction Practice and Clinical Outcomes in Profound Hyponatremia.
Geoghegan P; Harrison AM; Thongprayoon C; Kashyap R; Ahmed A; Dong Y; Rabinstein AA; Kashani KB; Gajic O
Mayo Clin Proc; 2015 Oct; 90(10):1348-55. PubMed ID: 26434962
[TBL] [Abstract][Full Text] [Related]
4. Overcorrection and undercorrection with fixed dosing of bolus hypertonic saline for symptomatic hyponatremia.
Pelouto A; Refardt JC; Christ-Crain M; Zandbergen AAM; Hoorn EJ
Eur J Endocrinol; 2023 Mar; 188(3):322-330. PubMed ID: 36881992
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of rapid intermittent correction compared with slow continuous correction with hypertonic saline in patients with moderately severe or severe symptomatic hyponatremia: study protocol for a randomized controlled trial (SALSA trial).
Lee A; Jo YH; Kim K; Ahn S; Oh YK; Lee H; Shin J; Chin HJ; Na KY; Lee JB; Baek SH; Kim S
Trials; 2017 Mar; 18(1):147. PubMed ID: 28356136
[TBL] [Abstract][Full Text] [Related]
6. Risk of Overcorrection in Rapid Intermittent Bolus vs Slow Continuous Infusion Therapies of Hypertonic Saline for Patients With Symptomatic Hyponatremia: The SALSA Randomized Clinical Trial.
Baek SH; Jo YH; Ahn S; Medina-Liabres K; Oh YK; Lee JB; Kim S
JAMA Intern Med; 2021 Jan; 181(1):81-92. PubMed ID: 33104189
[TBL] [Abstract][Full Text] [Related]
7. Treatment of symptomatic hyponatremia with hypertonic saline: a real-life observational study.
Chifu I; Gerstl A; Lengenfelder B; Schmitt D; Nagler N; Fassnacht M; Weismann D
Eur J Endocrinol; 2021 May; 184(5):647-655. PubMed ID: 33635825
[TBL] [Abstract][Full Text] [Related]
8. Hyponatremia in ICU.
Pillai KS; Trivedi TH; Moulick ND
J Assoc Physicians India; 2018 May; 66(5):48-52. PubMed ID: 30477055
[TBL] [Abstract][Full Text] [Related]
9. The impact of the correction of hyponatremia during hospital admission on the prognosis of SARS-CoV-2 infection.
de La Flor JC; Gomez-Berrocal A; Marschall A; Valga F; Linares T; Albarracin C; Ruiz E; Gallegos G; Gómez A; de Los Santos A; Rodeles M
Med Clin (Barc); 2022 Jul; 159(1):12-18. PubMed ID: 34635318
[TBL] [Abstract][Full Text] [Related]
10. The Role of Desmopressin in the Management of Severe, Hypovolemic Hyponatremia: A Single-Center, Comparative Analysis.
Ward FL; Tobe SW; Naimark DMJ
Can J Kidney Health Dis; 2018; 5():2054358118761051. PubMed ID: 29593879
[TBL] [Abstract][Full Text] [Related]
11. Predictors of outcome in hospitalized patients with severe hyponatremia.
Nzerue CM; Baffoe-Bonnie H; You W; Falana B; Dai S
J Natl Med Assoc; 2003 May; 95(5):335-43. PubMed ID: 12793790
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for sodium overcorrection in non-hypovolemic hyponatremia patients treated with tolvaptan.
Kim Y; Lee N; Lee KE; Gwak HS
Eur J Clin Pharmacol; 2020 May; 76(5):723-729. PubMed ID: 32055900
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a protocol for hypertonic saline administration in acute euvolemic symptomatic hyponatremia: A prospective observational trial.
Bhaskar E; Kumar B; Ramalakshmi S
Indian J Crit Care Med; 2010 Oct; 14(4):170-4. PubMed ID: 21572746
[TBL] [Abstract][Full Text] [Related]
14. Patients presenting with severe hypotonic hyponatremia: etiological factors, assessment, and outcomes.
Vu T; Wong R; Hamblin PS; Zajac J; Grossmann M
Hosp Pract (1995); 2009 Dec; 37(1):128-36. PubMed ID: 20877181
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors of overcorrection in patients presenting with severe hyponatremia to the emergency department.
Sumi H; Imai N; Shibagaki Y
Clin Exp Nephrol; 2022 Nov; 26(11):1086-1091. PubMed ID: 35870090
[TBL] [Abstract][Full Text] [Related]
16. Diabetes prevalence and outcomes in hospitalized cardiorenal-syndrome patients with and without hyponatremia.
Pliquett RU; Schlump K; Wienke A; Bartling B; Noutsias M; Tamm A; Girndt M
BMC Nephrol; 2020 Sep; 21(1):393. PubMed ID: 32912147
[TBL] [Abstract][Full Text] [Related]
17. Hyponatremia management among patients admitted to tertiary hospital: A retrospective evaluation.
Zurnuq S; Aljurfi M; Albekery M; Shawaqfeh MS; Elmubark A; Vasudevan S; Alharbi S; Alkatheri M; Albekairy AM; Al Katheri AA
SAGE Open Med; 2022; 10():20503121221095333. PubMed ID: 35509952
[TBL] [Abstract][Full Text] [Related]
18. Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes.
Doshi SM; Shah P; Lei X; Lahoti A; Salahudeen AK
Am J Kidney Dis; 2012 Feb; 59(2):222-8. PubMed ID: 22001181
[TBL] [Abstract][Full Text] [Related]
19. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.
Sood L; Sterns RH; Hix JK; Silver SM; Chen L
Am J Kidney Dis; 2013 Apr; 61(4):571-8. PubMed ID: 23266328
[TBL] [Abstract][Full Text] [Related]
20. Effect of Electrolyte Imbalance on Mortality and Late Acute Kidney Injury in Hospitalized COVID-19 Patients.
Sabaghian T; Honarvar M; Safavi-Naini SAA; Sadeghi Fadaki AS; Pourhoseingholi MA; Hatamabadi H
Iran J Kidney Dis; 2022 Jul; 16(4):228-237. PubMed ID: 35962637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
